Xadago European Union - English - EMA (European Medicines Agency)

xadago

zambon spa - safinamide methanesulfonate - parkinson disease - anti-parkinson drugs - xadago is indicated for the treatment of adult patients with idiopathic parkinson’s disease (pd) as add-on therapy to a stable dose of levodopa (l-dopa) alone or in combination with other pd medicinal products in mid-to late-stage fluctuating patients.

Fluimucil 200 mg granules for oral solution Ireland - English - HPRA (Health Products Regulatory Authority)

fluimucil 200 mg granules for oral solution

zambon s.p.a. - acetylcysteine - granules for oral solution - 200 milligram(s) - mucolytics; acetylcysteine - fluimucil is indicated in acute and chronic bronchitis and other respiratory conditions associated with the production of viscous mucus. fluimucil is also indicated for use in patients with abdominal complications associated with cystic fibrosis.

Monuril 3 g granules for oral solution Ireland - English - HPRA (Health Products Regulatory Authority)

monuril 3 g granules for oral solution

zambon s.p.a. - fosfomycin trometamol - granules for oral solution - 3 gram(s) - other antibacterials; fosfomycin

Fluimucil acetylcysteine 600 mg effervescent tablets Malta - English - Medicines Authority

fluimucil acetylcysteine 600 mg effervescent tablets

zambon spa via lillo del duca, 10, 20091 bresso (milan), italy - effervescent tablet - acetylcysteine 600 mg - cough and cold preparations